NYU Langone study: inflammation levels tied to severe AML

AI tool helps to diagnose and predict severity of lung cancers

A computer program based on data from nearly a half-million tissue images and powered by artificial intelligence can accurately diagnose cases of adenocarcinoma, the most common form of lung cancer, a study published June 11 in Nature Communications shows.

June 14, 2024

Vol.50 No.24

In Brief

Jonathan Yang named director of clinical research at NYU Brain and Spine Tumor Center

Jonathan T. Yang has joined NYU Langone Health’s Perlmutter Cancer Center as director of clinical research at its Brain and Spine Tumor Center.

May 24, 2024

Vol.50 No.21

Clinical Roundup

Orca-T improves AML survival in phase Ib trial subgroup

Orca Bio will present new data at the 2024 American Society of Clinical Oncology Annual Meeting in Chicago.

May 24, 2024

Vol.50 No.21

Clinical Roundup

Older adults with aggressive blood cancer are responsive to treatment and show prolonged survival

Standard of care treatment for acute myeloid leukemia is safe and effective for adults over 80, according to a study published in Blood Neoplasia. For roughly a quarter of patients, this treatment can durably prolong survival.

May 17, 2024

Vol.50 No.20

Clinical Roundup

Lower MRD prior to HCT associated with better outcomes in FLT3-ITD AML

Patients in remission after being treated for a high-risk blood cancer are likely to have better outcomes if no trace of the cancer is detectable before the patients receive donor blood cells.

May 03, 2024

Vol.50 No.18

In Brief

NYU Dentistry’s Pain Research Center receives $8M NIH grant to study oral cancer pain

Researchers at NYU Dentistry’s Pain Research Center have been awarded a five-year, $8 million NIH grant to study signaling mechanisms that generate oral cancer pain. The funding is part of the NIH’s Helping to End Addiction Long-term Initiative, which supports the development of safe and effective therapeutics to treat pain in an effort to end the opioid crisis.

April 12, 2024

Vol.50 No.15

NYU Langone study: inflammation levels tied to severe AML

YOU MAY BE INTERESTED IN

AI tool helps to diagnose and predict severity of lung cancers

Jonathan Yang named director of clinical research at NYU Brain and Spine Tumor Center

Orca-T improves AML survival in phase Ib trial subgroup

Older adults with aggressive blood cancer are responsive to treatment and show prolonged survival

Lower MRD prior to HCT associated with better outcomes in FLT3-ITD AML

NYU Dentistry’s Pain Research Center receives $8M NIH grant to study oral cancer pain

Renew today!

Subscriber content

Login